Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Colleoni

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|April 23, 2004
Correlation between histological subtype and type of bcl-2/IgH rearrangement in follicular lymphomasGisele W B Colleoni, Luiz Cláudio C Duarte, Fábio R Kerbauy, et al.
International Journal of Dermatology|May 3, 2006
Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphomaF H Sakamoto, G W B Colleoni, S P Teixeira, et al.
Leukemia & Lymphoma|September 17, 2004
Detection and possible prognostic relevance of p53 gene mutations in diffuse large B-cell lymphoma. An analysis of 51 cases and review of the literatureFábio R Kerbauy, Gisele W B Colleoni, Sara T O Saad, et al.
Acta Oncologica (Stockholm, Sweden)|December 24, 2003
2-Chloro-deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to non-Hodgkin's lymphomaGisele W B Colleoni, Luiz Cláudio C Duarte, Fábio Rodrigues Kerbauy, et al.
Experimental Hematology|February 13, 2009
Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myelomaValéria C C Andrade, André L Vettore, Maria Regina Regis Silva, et al.
Cancer Letters|June 25, 2017
Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patientsMariana B de Oliveira, Veruska L Fook-Alves, Angela I P Eugenio, et al.
Clinics (Sao Paulo, Brazil)|November 17, 2011
Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patientsLeina Y Etto, Vânia Maris Morelli, Vanderleia C Silva, et al.
Blood Cancer Journal|August 27, 2016
Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patientsG R A de Mendonça, A B C Brito, R M Rocha, et al.
Cancer Immunity|February 2, 2008
Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patientsValéria C C Andrade, André L Vettore, Roberta S Felix, et al.
Cancer Letters|January 28, 2009
SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesisRoberta S Felix, Gisele W B Colleoni, Otavia L Caballero, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|April 23, 2004
Correlation between histological subtype and type of bcl-2/IgH rearrangement in follicular lymphomasGisele W B Colleoni, Luiz Cláudio C Duarte, Fábio R Kerbauy, et al.
International Journal of Dermatology|May 3, 2006
Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphomaF H Sakamoto, G W B Colleoni, S P Teixeira, et al.
Leukemia & Lymphoma|September 17, 2004
Detection and possible prognostic relevance of p53 gene mutations in diffuse large B-cell lymphoma. An analysis of 51 cases and review of the literatureFábio R Kerbauy, Gisele W B Colleoni, Sara T O Saad, et al.
Acta Oncologica (Stockholm, Sweden)|December 24, 2003
2-Chloro-deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to non-Hodgkin's lymphomaGisele W B Colleoni, Luiz Cláudio C Duarte, Fábio Rodrigues Kerbauy, et al.
Experimental Hematology|February 13, 2009
Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myelomaValéria C C Andrade, André L Vettore, Maria Regina Regis Silva, et al.
Cancer Letters|June 25, 2017
Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patientsMariana B de Oliveira, Veruska L Fook-Alves, Angela I P Eugenio, et al.
Clinics (Sao Paulo, Brazil)|November 17, 2011
Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patientsLeina Y Etto, Vânia Maris Morelli, Vanderleia C Silva, et al.
Blood Cancer Journal|August 27, 2016
Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patientsG R A de Mendonça, A B C Brito, R M Rocha, et al.
Cancer Immunity|February 2, 2008
Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patientsValéria C C Andrade, André L Vettore, Roberta S Felix, et al.
Cancer Letters|January 28, 2009
SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesisRoberta S Felix, Gisele W B Colleoni, Otavia L Caballero, et al.
Pageof 6